Advertisement

Plant Foods for Human Nutrition

, Volume 72, Issue 2, pp 126–133 | Cite as

Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial

  • Hossein Moazzen
  • Mohammad AlizadehEmail author
Original Paper

Abstract

The aim of this study is to investigate the simultaneous effect of pomegranate juice on components of the metabolic syndrome, including high sensitive C-reactive protein (hs-CRP) as an inflammatory index and glycemic and lipid profile indices in patients with metabolic syndrome. In a double- blind 2*2 crossover study, 30 individuals suffering from metabolic syndrome received a daily dose of 500 mL pomegranate juice for a period of one week. After one week of wash out period, they received a placebo for one week. Lipid profile, blood glucose control indices including fasting blood glucose, fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), systolic and diastolic blood pressure, and hs-CRP were measured at the beginning and end of the study. To analyze the data, a repeated measure analysis of variance and a t-test were performed. The results indicated that in comparison to the placebo, pomegranate juice was more effective in reducing the systolic and diastolic blood pressure (p = 0.00) and hs-CRP (p = 0.018). The level of triglyceride (p = 0.030) and very low-density lipoproteins cholesterol (VLDL-C) (p = 0.014) were increased after the consumption of pomegranate juice, as opposed to the baseline condition. The rest of lipid profile, fasting blood glucose (FBS), insulin, and HOMA-IR of the participants did not show any significant difference. Natural pomegranate juice supplementation lowered the level of systolic and diastolic blood pressure in patients with metabolic syndrome as well as their blood hs-CRP. However, it also increased their triglyceride and VLDL-C.

Keywords

Metabolic syndrome Cardiovascular disease Pomegranate juice Lipid profile 

Abbreviations

ACE

Angiotensin converting enzyme

ANOVA

Analysis of variance

DPPHsc

2, 2-diphenil-1-picrylhydrazyl radical scavenging activity

FBS

Fasting blood glucose

HDL-C

High-density lipoproteins cholesterol

HOMA-IR

Homeostatic model assessment of insulin resistance

Hs-CRP

High sensitivity C-reactive protein

IL-6

Interleukin-6

LDL-C

Low-density lipoproteins cholesterol

Ta

Total acidity

TNF-α

Tumor necrosis factor-α

TSS

Total soluble solids

VLDL-C

Very low-density lipoproteins cholesterol

Notes

Acknowledgements

This manuscript extracted from a master’s thesis in Nutrition and the authors would like to thank the Urmia University of Medical Sciences for providing the necessary facilities and financial support. We also feel obliged to express our gratitude to Dr. Parastu Dorrimanesh for editing the manuscript and to all those participating in this study for their sincere cooperation.

Compliance with Ethical Standards

Conflicts of Interests

The authors declare that they have no conflict of interests.

Source of Funding and Authorship

This research study was carried out by the financial support from Urmia University of Medical Sciences.

References

  1. 1.
    Batiste MC, Schaefer EJ (2002) Diagnosis and management of lipoprotein abnormalities. Nutr Clin Care 5(3):115–123CrossRefGoogle Scholar
  2. 2.
    Gower BA, Muñoz J, Desmond R, Hilario-Hailey T, Jiao X (2006) Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use. Obesity 14(6):1046–1055CrossRefGoogle Scholar
  3. 3.
    Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB (2005) Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 165(7):777–783CrossRefGoogle Scholar
  4. 4.
    Diamantopoulos E, Andreadis E, Tsourous G, Ifanti G, Katsanou P, Georgiopoulos D, Vassilopoulos C, Dimitriadis G, Raptis S (2006) Metabolic syndrome and prediabetes identify overlapping but not identical populations. Exp Clin Endocrinol Diabetes 114(7):377–383CrossRefGoogle Scholar
  5. 5.
    Yao LH, Giang YM, Shi J, Tomas-Barberan FA, Datta N, Singanusong R, Chen SS (2004) Flavonoids in food and their health benefits. Plant Foods Hum Nutr 59(3):113–122CrossRefGoogle Scholar
  6. 6.
    Szajdek A, Borowska EJ (2008) Bioactive compounds and health-promoting properties of berry fruits: a review. Plant Foods Hum Nutr 63(4):147–156Google Scholar
  7. 7.
    Cavallini G, Dacha M, Potenza L, Ranieri A, Scattino C, Castagna A, Bergamini E (2014) Use of red blood cell membranes to evaluate the antioxidant potential of plant extracts. Plant Foods Hum Nutr 69(2):108–114CrossRefGoogle Scholar
  8. 8.
    Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, Heber D (2008) Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem 56(4):1415–1422CrossRefGoogle Scholar
  9. 9.
    Sahebkar A, Ferri C, Giorgini P, Bo S, Nachtigal P, Grassi D (2017) Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 115:149–161CrossRefGoogle Scholar
  10. 10.
    Sahebkar A, Gurban C, Serban A, Andrica F, Serban MC (2016a) Effects of supplementation with pomegranate juice on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine 23(11):1095–1102CrossRefGoogle Scholar
  11. 11.
    Sahebkar A, Simental-Mendia LE, Giorgini P, Ferri C, Grassi D (2016b) Lipid profile changes after pomegranate consumption: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine 23(11):1103–1112CrossRefGoogle Scholar
  12. 12.
    Hosseini B, Saedisomeolia A, Wood LG, Yaseri M, Tavasoli S (2016) Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: a randomized controlled clinical trial. Complement Ther Clin Pract 22:44–50CrossRefGoogle Scholar
  13. 13.
    Shishehbor F, Mohammad Shahi M, Zarei M, Saki A, Zakerkish M, Shirani F, Zare M (2016) Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: a quasi-experimental study. Int J Endocrinol Metab 14(1):e33835CrossRefGoogle Scholar
  14. 14.
    Shema-Didi L, Sela S, Ore L, Shapiro G, Geron R, Moshe G, Kristal B (2012) One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic Biol Med 53(2):297–304CrossRefGoogle Scholar
  15. 15.
    Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice. Am J Clin Nutr 71(5):1062–1076Google Scholar
  16. 16.
    Ahmadi M, Ghasemnezhad M, Meighani H, Kavoosi M (2016) A comparison of conventional, integrated and organic management systems on the quality of pomegranate fruit cv. “Robab-e-shiraz”. J Hortic Sci 30(3):447–456Google Scholar
  17. 17.
    Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Liker H, Hayek T (2004) Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23(3):423–433CrossRefGoogle Scholar
  18. 18.
    Lynn A, Hamadeh H, Leung WC, Russell JM, Barker ME (2012) Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women. Plant Foods Hum Nutr 67(3):309–314CrossRefGoogle Scholar
  19. 19.
    Aviram M, Dornfeld L (2001) Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158(1):195–198CrossRefGoogle Scholar
  20. 20.
    Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48(10):4581–4459CrossRefGoogle Scholar
  21. 21.
    Li Q, Youn JY, Cai H (2015) Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens 33(6):1128–1136CrossRefGoogle Scholar
  22. 22.
    Farvid MS, Jalali M, Siassi F, Saadat N, Hosseini M (2004) The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr 23(3):272–279CrossRefGoogle Scholar
  23. 23.
    Schmitt CA, Dirsch VM (2009) Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 21(2):77–91CrossRefGoogle Scholar
  24. 24.
    Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C (2006) Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide 15(2):93–102CrossRefGoogle Scholar
  25. 25.
    Rao F, Tian H, Li W, Hung H, Sun F (2016) Potential role of punicalagin against oxidative stress induced testicular damage. Asian J Androl 18(4):627–632CrossRefGoogle Scholar
  26. 26.
    Rivara MB, Mehrotra R, Linke L, Ruzinski J, Ikizler TA, Himmelfarb J (2015) A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients. J Ren Nutr 25(1):40–49CrossRefGoogle Scholar
  27. 27.
    Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S, Rafieian-Kopaei M (2013) Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res 28(2):193–199CrossRefGoogle Scholar
  28. 28.
    Rasheed Z, Akhtar N, Anbazhagan AN, Ramamurthy S, Shukla M, Haqqi TM (2009) Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP kinases and NF-κB in human KU812 cells. J Inflamm (Lond) 6(1):1CrossRefGoogle Scholar
  29. 29.
    Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54(3):980–985CrossRefGoogle Scholar
  30. 30.
    Boussetta T, Raad H, Letteron P, Gougerot-Pocidalo M-A, Marie J-C, Driss F, El-Benna J (2009) Punicic acid a conjugated linolenic acid inhibits TNFα-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One 4(7):e6458CrossRefGoogle Scholar
  31. 31.
    Basu A, Newman ED, Bryant AL, Lyons TJ, Betts NM (2013) Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J Nutr Metab 2013:708381CrossRefGoogle Scholar
  32. 32.
    Mathew AS, Capel-Williams GM, Berry SE, Hall WL (2012) Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure. Plant Foods Hum Nutr 67(4):351–357CrossRefGoogle Scholar
  33. 33.
    Havel PJ (2005) Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63(5):133–157CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Student Research CommitteeUrmia University of Medical SciencesUrmiaIran
  2. 2.Department of Nutrition, Food and Beverages Safety Research Center, Faculty of MedicineUrmia University of Medical SciencesUrmiaIran

Personalised recommendations